Tolemy Bio is an AI-driven biomanufacturing company (UK parent with a Spanish subsidiary) building a 'control panel for the cell' to design and optimize cell-culture media and bioprocess conditions. We integrate multi-omics process data and metabolic modeling to program cell phenotype - initially for T-cell therapies and HEK293 systems-reducing R&D cycles and improving yield function (e.g. reduced exhaustion/senescence) and cost. The business combines a SaaS platform (data- model- optimize).